ArticleNature methods2024
De novo identification of CD4
Open access · hybridAbstract read
In one paragraph
Article in Nature methods, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 19 citations in OpenAlex.
- Discovery of Post-Translationally Modified Epitopes in Autoimmunity: Someone Has to Fish so Everyone Can Eat.Immunological reviews · 2026Review
- Hybrid Insulin Peptides as Antigens and Tolerogens for Pathogenic T Cells in Autoimmune Diabetes.Immunological reviews · 2026Review
- Beyond Sequence: Posttranslational Remodeling of Antigens in Autoimmunity.Immunological reviews · 2026Review
- Unbiased discovery of autoreactive type 1 diabetes T-cell receptors that bind specific hybrid insulin peptides.Research square · 2026Article
- The challenge and promise of studying human antigen-specific T cells.Nature reviews. Immunology · 2026Review
- Lung mucosal and systemic responses at single-cell resolution in an aerosolized Mycobacterium bovis BCG human challenge model.Cell reports. Medicine · 2026Article
- Hallmarks and correlates of effective adoptive cell immunotherapy for cancer.Nature reviews. Immunology · 2026Review
- Coincident epithelial signals restrain commensal-specific CD8αβbioRxiv : the preprint server for biology · 2026Article
- Identification of a type 1 diabetes-associated T cell receptor repertoire signature from the human peripheral blood.Science advances · 2026Article
- T Cell Antigen Discovery Using Cell-Based Epitope Libraries.Methods in molecular biology (Clifton, N.J.) · 2026Article
- TIRTL-seq: deep, quantitative and affordable paired TCR repertoire sequencing.Nature methods · 2026Article
- Developing T Cell Epitope-Based Vaccines Against Infection: Challenging but Worthwhile.Vaccines · 2025Review
- Immunopeptidomics for autoimmunity: unlocking the chamber of immune secrets.NPJ systems biology and applications · 2025Review
- Year in review 2024.Nature methods · 2025Article
- The Evolving T Cell Receptor Recognition Code: The Rules Are More Like Guidelines.Immunological reviews · 2025Review
- Probing TCR Specificity Using Artificial In Vivo Diversification of CDR3 Regions.European journal of immunology · 2025Article
- The beta cell-immune cell interface in type 1 diabetes (T1D).Molecular metabolism · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 2 institutions in 1 country.
Paul M ZdinakDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Nishtha Trivedi *Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Stephanie Grebinoski *Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Jessica TorreyDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Eduardo Zarate MartinezDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0001-6411-3563
Salome MartinezDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Louise HicksDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Rashi RanjanDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-8303-7815
Venkata Krishna Kanth MakaniDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Mary Melissa RolandDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Lyubov KubloDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Sanya ArshadDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Mark S AndersonDiabetes Center, University of California San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-3093-4758
Dario A A VignaliDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-2771-5992
Alok V JoglekarDepartment of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. joglekar@pitt.edu.ORCID http://orcid.org/0000-0001-7554-7447
University of Pittsburgh · USUniversity of California, San Francisco · US
Funding
Autoimmunity and Immunopathology Training ProgramT32AI089443 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SHLOMCHIK, MARK J · 2010 to 2024
$6.6MSignaling via MHC: engineering immune cells with new capabilitiesDP2AI176138 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOGLEKAR, ALOK · 2022 to 2025
$2.3MIdentification of the cognate epitopes of autoreactive T cells in Type 1 DiabetesR03DK127447 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOGLEKAR, ALOK · 2020 to 2021
$313kNIAID NIH HHS DP2 AI176138NIAID NIH HHS T32 AI089443NIDDK NIH HHS R03 DK127447U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) 5T32AI089443-14U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases) 1R03DK127447-01U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD) DP2 OD033187-01
Abstract
CD4
Indexed as
CD4-Positive T-LymphocytesEpitopes, T-LymphocyteHistocompatibility Antigens Class IIAnimalsAntigen PresentationDiabetes Mellitus, Type 1HumansMiceMice, Inbred NODPeptidesReceptors, Antigen, T-CellSingle-Cell AnalysisEpitopes, T-LymphocyteHistocompatibility Antigens Class IIPeptidesReceptors, Antigen, T-Cell
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.